September 2026 Quarterly Activities Report and Appendix 4C
Filed with ASX ·
6ix is reading this filing.
Earlier from TrivarX
- Syntro Health Appointed to Support Stabl-Im Clinical Program
- Stabl-Im Clinical Development Update
- June 2026 Quarterly Activities Report and Appendix 4C
- Stabl-Im clinical trial supply milestone achieved
- CRO Engaged to Advance Stabl-Im Phase 1 Trial
Follow TrivarX into a list and get an email when it puts out news.
Follow TrivarX